Company: PFSA
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112723
Chunk: 137

Company: Profusa, Inc.
Filing Date: 2025-11-19
Form: 10-Q
Item: Part I, Item 8
Chunk 137
---
isting. At that time, the Company may appeal the delisting determination to a hearings panel. The Company
is monitoring the MVLS of its listed securities and is considering available options to regain compliance with Nasdaq’s continued
listing standards. There can be no assurance that the Company will be able to regain compliance with Nasdaq Listing Rule 5450(b)(2)(A)
or maintain compliance with other applicable Nasdaq listing requirements.

7

On September 11, 2025, the Company received a second notice (the “Bid
Price Notice”, and together with the MVLS Notice, the “Notices”) from Nasdaq notifying the Company that, based upon
its review of the closing bid price of the Common Stock, from July 29, 2025 to September 10, 2025, the Company no longer meets Nasdaq
Listing Rule 5450(a)(1), which requires companies listed on the Nasdaq Global Market to maintain a minimum bid price of $1.00 per share.
The Company has been provided a compliance period of 180 calendar days, or until March 10, 2026, to regain compliance with Nasdaq Listing
Rule 5450(a)(1). If at any time during this compliance period, the Common Stock has a closing bid price bid price of at least $1.00 per
share for a minimum of ten consecutive business days, Nasdaq will provide the Company with written confirmation of compliance and this
matter will be closed, provided, however that Nasdaq may, in its discretion, require the Company to maintain the minimum bid price for
a period in excess of ten consecutive business days, but generally no more than 20 consecutive business days, before determining that
the Company has demonstrated an ability to maintain long-term compliance.

In the event the Company does not regain compliance with Nasdaq
Listing Rule 5450(a)(1) prior to the expiration of the compliance period, then Nasdaq may grant the Company a second 180 calendar
day period to regain compliance, provided, among other things, the Company meets the continued listing requirement for market value
of publicly-held shares and all other initial listing standards for The Nasdaq Global Market, other than the minimum bid price
requirement, and notifies Nasdaq of its intent to cure the deficiency. If the Company does not regain compliance within the allotted
compliance periods, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Common Stock will be
subject to delisting.